Oseltamivir

Treatment of Influenza

Oseltamivir is used to treat acute, uncomplicated illness caused by the influenza virus (the flu). It is effective against both influenza A and influenza B. For treatment to be most effective, it must be started within 48 hours of the first appearance of symptoms, such as fever, cough, sore throat, and body aches. It is approved for treatment in:

• Adults
• Infants as young as 2 weeks of age

Prevention of Influenza

This medication is also used to prevent the flu in people who have been exposed to the virus but do not yet have symptoms. This may include situations where a family member has the flu or during a community outbreak. For prevention, it is approved for use in:

• Adults
• Children 1 year of age and older

Important Considerations

• Not a Vaccine: Oseltamivir is not a substitute for the annual flu vaccine. Health experts recommend getting the flu shot every year as the primary way to prevent infection.
• Viral Infections Only: This drug only treats infections caused by influenza viruses. It does not work for the common cold or other viral or bacterial infections.
• Timing: The medication is most effective when taken as soon as possible after symptoms start or after exposure to the virus occurs.

Mechanism of Action

Oseltamivir belongs to a class of drugs known as neuraminidase inhibitors. It is designed to target the influenza virus, specifically types A and B.

When the flu virus infects a cell, it uses an enzyme called neuraminidase to break out of that cell and spread to other healthy cells. Oseltamivir works by:

• Binding to the neuraminidase enzyme on the surface of the virus.
• Preventing the virus from detaching from the infected cell.
• Stopping the virus from moving through the respiratory tract to infect new cells.

By limiting the spread of the virus, the medication can help shorten the duration of flu symptoms and reduce the severity of the illness. It is most effective when started shortly after symptoms begin, as this is when the virus is actively replicating and spreading.

It is important to note that oseltamivir is not a substitute for the annual flu vaccine. It specifically targets viruses and does not work against infections caused by bacteria.

Common Side Effects

• Nausea
• Vomiting
• Headache
• Stomach pain
• Diarrhea
• Dizziness

Taking this medication with food may help reduce the likelihood of experiencing nausea or vomiting.

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious symptoms:

• Signs of an allergic reaction, such as hives, skin rash, or swelling of the face, lips, or tongue.
• Severe skin reactions, including blistering, peeling, or red skin rashes.
• New or worsening behavioral changes, especially in children and teenagers, such as confusion, agitation, hallucinations, or self-harm.
• Chest pain or difficulty breathing.

Neuropsychiatric Events

People with the flu, especially children and adolescents, may be at an increased risk of seizures, confusion, or abnormal behavior early in their illness. These events may occur shortly after starting oseltamivir or may occur even if the medication is not taken. Patients should be monitored for signs of unusual behavior, self-injury, or delirium.

Serious Skin and Allergic Reactions

Rare but serious skin conditions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported. Additionally, some people may experience severe allergic reactions, including anaphylaxis or swelling of the face, lips, or tongue. Treatment is typically stopped if a severe rash or signs of a serious allergic reaction develop.

Limitations and Other Considerations

• Flu Vaccination: This medication is not a substitute for the annual flu vaccine.
• Bacterial Infections: Oseltamivir only treats the influenza virus. It does not treat bacterial infections that can sometimes develop as complications of the flu.
• Kidney Function: People with kidney disease may need a dosage adjustment based on how well their kidneys are working.
• Fructose Intolerance: The liquid form of this medication may contain sorbitol, which can cause issues for individuals with hereditary fructose intolerance.

Pregnancy

Pregnant women are at an increased risk for severe complications from the influenza virus, such as pneumonia and respiratory distress. While clinical data are limited, available studies of pregnant women taking oseltamivir have not shown an increased risk of major birth defects or other adverse pregnancy outcomes compared to the general population.

Healthcare providers typically weigh the risks of the flu—which can include high fever and harm to the fetus—against the potential risks of the medication. If you are pregnant or planning to become pregnant, discuss the benefits and risks of oseltamivir with your doctor.

Breastfeeding

Oseltamivir and its active metabolite pass into breast milk in very small amounts. These levels are generally considered too low to cause significant side effects in a nursing infant. However, it is important to consult with a healthcare professional before using this medication while breastfeeding to ensure it is appropriate for your specific situation.

Available Forms

Oseltamivir is primarily available in the following oral formulations:

• Capsules: These are solid oral dosage forms intended to be swallowed whole.
• Powder for Oral Suspension: This is a dry powder that is reconstituted into a liquid by a pharmacist. It is often used for children or adults who have difficulty swallowing capsules.

Alternative Administration

In certain situations where the manufactured liquid suspension is not available, healthcare providers may provide instructions for preparing an emergency liquid version. This typically involves opening the capsules and mixing the contents with a sweetened liquid, such as chocolate syrup or corn syrup, to mask the bitter taste of the medication.

FDA Approval and Indications

Oseltamivir was first approved by the U.S. Food and Drug Administration (FDA) in 1999. It is indicated for the treatment of acute, uncomplicated illness due to influenza A and B infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. It is also approved for the prophylaxis (prevention) of influenza in patients 1 year of age and older.

Safety Communications

The FDA has issued safety communications regarding neuropsychiatric events associated with oseltamivir use. These events, which include self-injury, confusion, and delirium, have been reported primarily in pediatric patients. While a direct link to the drug has not been established—as influenza itself can cause similar symptoms—the FDA requires that healthcare providers and caregivers monitor patients for signs of abnormal behavior throughout the treatment period.

Regulatory Status

Oseltamivir is available as a prescription-only medication. There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) associated with its use. Generic versions of the medication have been approved by the FDA and are widely available.

How Oseltamivir Treats the Flu

Oseltamivir belongs to a class of drugs called neuraminidase inhibitors. It is specifically designed to treat acute, uncomplicated influenza caused by both type A and type B viruses. It works by blocking an enzyme the virus needs to spread from infected cells to healthy cells.

Timing and Effectiveness

For the treatment to be most effective, it must be started as soon as possible, ideally within 48 hours of the first signs of illness. When taken correctly, oseltamivir can:

• Shorten the duration of flu symptoms, such as fever, cough, and sore throat, by approximately one to two days.
• Reduce the risk of developing secondary complications, such as pneumonia or ear infections, that may require antibiotics.
• Decrease the severity of symptoms while the illness lasts.

Usage in Different Groups

Oseltamivir is approved for treating the flu in adults and children, including infants as young as 2 weeks old. While it helps manage the infection, it is not a substitute for the annual flu vaccine, which remains the primary method for preventing influenza.